GCTK GCTK
Company Profile ↓Company Overview
GCTK (GCTK) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 28.3% CAGR over the past five years.
Trades at an undemanding P/E of 0.0.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +378.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 28.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 28.32% |
| 1 Year: | 378.29% |
Stock Price Performance
| 1 Year: | -91.28% |
| 6 Months: | -70.34% |
| 3 Months: | -28.08% |
| 1 Month: | +45.83% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)53.93 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 28.3% over 5 years.
CONS
- Trading 95.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2013 | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.74K | 20.90K | 28.21K | 15.28K | - | 25.56K | 110.52K | 4.17K | 2.17K | 97 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | -687.82K | -831.79K | -727.40K | -887.19K | -882.33K | -830.69K | -880.70K | -1.10M | -1.12M | -1.26M | -1.58M | -1.49M | 2.60M | -2.65M | -2.65M | 1.91M | -2.01M | -1.61M | 1.03M | -894.31K | -980.47K | -756.00K | -611.00K | -887.00K | -896.00K | -873.00K | -767.00K | -1.09M | -1.12M | -929.00K | -1.28M | -1.18M | -2.22M | -2.95M | -4.49M | -3.25M | -3.50M | -4.80M | -4.31M | -4.20M |
| Net Income | -1.34M | -576.60K | -699.87K | -736.92K | 5.26M | -769.57K | -1.53M | -1.67M | -1.10M | -1.23M | -1.59M | -1.45M | -2.53M | -2.56M | -2.58M | 1.85M | -1.96M | -1.57M | -1.02M | -898.86K | -996.78K | -734.00K | -574.00K | -509.00K | -904.00K | -853.00K | -804.00K | -1.09M | -1.13M | -928.00K | -1.29M | -1.18M | -2.22M | -2.93M | -4.49M | -5.09M | -6.83M | -4.76M | -4.17M | -4.33M |
| Diluted EPS | - | -0.13 | -0.16 | - | 0.78 | -0.16 | - | -0.33 | -0.22 | - | -0.30 | -0.30 | - | -0.48 | -0.44 | - | -0.33 | -0.31 | - | -0.01 | -0.01 | - | -0.04 | -0.03 | - | -0.06 | -0.05 | - | -0.07 | -0.06 | -0.08 | 0.27 | -0.49 | -11.73 | 984.00 | 1,092.00 | 40.14 | 9.62 | 4.64 | 2.65 |
| R&D Expense | 504.25K | 461.30K | 495.21K | 451.08K | 454.79K | 421.70K | 478.32K | 557.98K | 560.19K | 579.50K | 880.70K | 695.44K | 581.54K | 616.82K | 635.48K | 592.70K | 691.89K | 534.13K | 425.12K | 401.12K | 377.38K | 413.00K | 379.00K | 476.00K | 309.00K | 321.00K | 447.00K | 460.00K | 469.00K | 434.00K | 642.00K | 627.00K | 1.69M | 2.15M | 3.59M | 2.06M | 1.87M | 3.15M | 3.17M | 2.13M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | 59.77K | 143.17K | 611.69K | 589.46K | 43.49K | 208.00K | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | -1.17M | -1.39M | -2.33M | -2.77M | -3.03M | -3.61M | -4.66M | -5.66M | 10.58M | -6.54M | 3.51M | -3.13M | -4.04M | -4.43M | -7.10M | -14.55M | -16.09M |
| Net Income | -350.29K | -288.23K | -1.06M | -1.28M | -1.59M | -1.53M | -1.20M | -2.79M | -2.36M | -2.77M | -9.80M | 2.98M | -5.84M | -5.41M | 10.33M | -6.72M | 3.52M | -2.70M | -4.07M | -4.43M | -7.10M | -22.60M | -19.39M |
| Diluted EPS | - | - | - | - | - | - | - | - | - | -0.52 | -1.95 | 0.37 | -1.15 | -1.08 | -1.87 | -4.74 | -0.02 | 0.19 | 0.26 | 0.29 | 34.18 | 4,106.00 | 31.22 |
| R&D Expense | - | - | - | - | - | - | 1.01M | 934.06K | 1.79M | 1.92M | 1.99M | 1.85M | 2.27M | 2.88M | 3.21M | 3.03M | 1.61M | 1.53M | 1.81M | 1.97M | 4.70M | 9.50M | 9.81M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2002 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | - | - | - | - | 1.77M | 2.18M | 814.57K | 2.76M | 6.35M | 2.13M | 2.46M | 1.67M | 688.19K | 1.10M | 10.61M | 6.26M | 2.44M | 4.91M | 5.93M | 7.84M |
| Total Equity | -22.86K | -388.18K | -487.63K | -270.06K | 1.78M | 542.22K | 49.75K | -775.74K | 598.14K | 968.24K | -503.07K | -11.06M | -4.83M | -6.97M | -10.95M | -16.57M | -2.87M | -1.41M | 8.98M | 5.16M | 1.23M | 3.20M | -13.00M | 2.83M |
| Cash & Equivalents | - | - | - | - | - | - | 526.30K | 62.03K | 1.49M | 1.90M | 543.41K | 2.39M | 5.83M | 608.70K | 148.84K | 53.78K | 97.08K | 419.00K | 9.82M | 6.06M | 2.31M | 4.49M | 5.62M | 7.38M |
| Total Liabilities | - | - | - | - | - | - | - | - | 1.17M | 1.21M | 1.32M | 9.46M | 3.43M | 2.17M | 3.37M | 4.82M | 3.56M | 2.51M | 1.62M | 1.11M | 1.21M | 1.71M | 18.93M | 5.01M |
| Current Liabilities | - | - | - | - | - | - | - | - | 288.10K | 283.04K | 457.95K | 310.91K | 1.00M | 1.51M | 2.35M | 3.69M | 3.22M | 2.27M | 1.34M | 883.00K | 1.01M | 1.51M | 1.27M | 4.77M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.16M | -1.37M | -1.92M | -2.30M | - | - | -4.57M | -5.31M | -5.90M | -4.89M | -3.90M | -3.50M | -3.77M | -3.73M | -6.56M | -12.49M | -15.24M |
| Investing Cash Flow | 228.92K | -29.32K | -40.18K | -17.73K | - | - | -203.17K | -76.45K | -19.47K | -5.37K | -23.00K | -53.00K | -1.00K | 1.00K | - | -104.00K | -96.00K |
| Financing Cash Flow | 466.26K | 2.90M | 2.38M | 953.53K | - | - | -460.86K | 4.94M | 5.75M | 4.96M | 4.20M | 13.01M | - | - | 8.73M | 13.74M | 17.04M |
| Capital Expenditure | -5.01K | -8.72K | -54.62K | -11.35K | -64.25K | -63.45K | -143.74K | -76.45K | -19.47K | -5.37K | -23.00K | -53.00K | -5.00K | -1.00K | - | -104.00K | -96.00K |
| Free Cash Flow | -1.17M | -1.38M | -1.97M | -2.31M | - | - | -4.71M | -5.39M | -5.91M | -4.90M | -3.92M | -3.55M | -3.77M | -3.73M | - | -12.59M | -15.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | -6,034.9% | -3,251.7% | -924.6% | 1,794.2% | -15,035.4% | 1,685.6% | - | - | - | - | - | - |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | 4,986.1% | -4,080.7% | -884.4% | 1,752.2% | -15,442.0% | 1,690.4% | - | - | - | - | - | - |
| ROE % | 90.2% | 59.1% | 390.9% | -72.2% | -293.8% | -3,073.3% | 155.0% | -466.2% | -244.2% | 551.1% | 88.6% | -61.7% | 83.8% | 49.4% | -62.3% | 233.7% | -249.0% | -30.0% | -78.9% | -360.6% | -222.0% | 173.8% | -685.6% |
| ROCE % | - | - | - | - | - | - | - | -93.8% | -122.8% | -777.8% | -123.8% | -67.4% | -748.2% | -5,016.0% | -524.3% | 258.1% | -298.1% | -33.8% | -75.1% | -311.0% | -209.4% | -312.4% | -525.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GCTK
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBTWDR0N3F0SHlNR1NDWlU5MC12WGw4Y253ZHZYa0dUR3hYWTdtb1VZeDRRN2VyLVV5RHd6cDloVzRnSTRJU0dNOXZjWWJMMkotTXdKWHVNY1o?oc=5" target="_blank">GlucoTrack (GCTK) Stock Surges Over 70% After Ho…
Glucotrack (GCTK) asks shareholders to approve $50M ELOC and convertible financing - Stock Titan
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOc29ZcWxuV29rUUJQTFJsTXJFVXVJZlk1RmJiWUp4cmg0cGdvZkhXempOcGxPWHRlX0RReGFLMkYzYUhZMjlBLTJTc3hpMnJfOVl4VlBnak9CSWszU2MxRGZTeUl0MzF3Mk1QbE1hMGRyMk16VWlhTGptVWZHZnJKc19wZkxhaFkwc1dlUk…
Market Movers | Winners: CYCU, GCTK, KSCP | Losers: MGRX, CCB, YYAI - Trefis
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOUkpDMDdfVm4yYjhSQVZLZG1MdTVHR19KRHZqSnJ2MDBKSkJJZ3NFYUJLOGRBQV8tRTZLU3FVVjU3TmdWQjZYSkZLVnhTdE1UMV9QRTQxSTMzQlVJNVFPWFZDVkFST3pTelJQLVFSSXlUR0xXVWRjRlRuZkowQmpJRXhETHVwZDRpNHprUm…
GlucoTrack surges as traders revisit Lōkahi merger and new financing package - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNYVpzYTYyUUQwaEwwaG5wdnVBSU5oU05wc21TM3ZJeVc0cnY3TV9lSFc0WUFCVHZDZVlNWTFHUHNUVzZjX3M2U194bG9ETWU2MlJGdkJXeGJmOHlTelVpdTVaU25nZFBoeGhLQTZpbmM0YTFWN2ZLRFU1d0lPMWdqQl9uZVlpMDNfVm5KM1…
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQUTV1UWJ6b1pyaWtCa3FHUmpraTYxUXliWlNPOFItZnh1c2FEQk5Zb0hZZF8tVW1OOThYODNtOHV1QllEMWxMR2ptNkV5QmJ4ZGMyenlFNTBSejF4cXd6RS1ScmlIczc5MVczNU1UUi1GYWpsM3R6WVlkV0k1dzNNMGp2SFcyd293cTkyUk…
$Glucotrack (GCTK.US)$ Given the current trend, the stock should see further gains in after-hours trading - Moomoo
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxNZ0luX1RuX1lRLVdCUWxVcmczVHoyNDhJWWdRaU1obnJ4cVpObi1ScnFpZ3U2T1Y1TkRBdEc0OVVlQzZod0JvZXJLN2FUdVpQS2JLMG5LSHZ0T2d0WmFPV1VrcXNVMlJIWThYenBTY3lZN3BWZHprN0lDdEVhSWExdkdSVDVNakZ6X1dPVW…
GCTK — Frequently Asked Questions
What is the current share price of GCTK?
As of 2026-08-05 17:25 PDT, GCTK trades at $0.52 on NASDAQ/NYSE. Its 52-week range is $0.28 to $10.59.
What is the P/E ratio of GCTK?
GCTK trades at a trailing price-to-earnings (P/E) ratio of 0.02.
Is GCTK a good stock to buy?
This page provides a data-driven analysis of GCTK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.